Value share of generic pharmaceuticals in Czechia 2011-2021

Published by
Matej Mikulic,
Nov 30, 2023
The generics share of the total pharmaceutical market value in the Czech Republic decreased to 21.5 percent since the previous year. Therefore, 2021 marks the lowest generics share during the observed period.
A country's pharmaceutical market is defined by sales of pharmaceutical products on the domestic market based on retail prices. However in some countries pharmaceutical sales may be based on ex-factory or wholesale prices, or may not take into account pharmaceutical consumption in hospitals.

Find more key insights for the generics share of the total pharmaceutical market value in countries like France, Portugal, and Norway.

Share of generic pharmaceuticals market value in Czechia from 2011 to 2021

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2023

Region

Czechia

Survey time period

2011 to 2021

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

8

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RomaniaSanofiBiotechnology in SpainBiotech drugsPfizer
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu